Mayo Clinic, along with 18 other health care organizations around the country, sent an open letter to Congress on July 22.
In addition, on July 19, 2009 the Chicago Tribune published “Bending the Curve on Health Spending” authored by Denis Cortese, M.D. and Jeff Korsmo.
9 Comments
Excellent letter. I agree 100 percent with the position of the Mayo Clinic. Unless payment is based on results, we’re doing nothing more than feeding the investment firms and hedge funds that operate the “floats” of the various insurance companies and the offshore bankers who launder money for these firms, physicians, and the CEOs of said companies.
An excellent letter! Porter & Teisberg showed value is the key to reform, and your support may turn the tide. Health care is a Complex Adaptive System. Imposing order in such an “unordered” system will only push it into chaos (David Snowden). Instead, influence applied at the inflection point can act as an attractor to move the system through emergence, with non-linear results. Politicians must be made to understand this, or we will destroy our system in the guise of improving it.
Can you explain to me by giving a specific example how “Pay for Value” would work. When I go to the doctor who & how would treatment be decided? What would I pay and what would Medicare and/or the Insurance pay.
Claude,
I can give you an example of “Pay for value”. You have an 88 year old mother in law who is bed-ridden. You can call in a house call from a doctor (cost $250-500?) who has never seen the woman before and is just there to punch a ticket and move on. OR – you can call in a PT (cost $100) who will spend an hour – teach her and her care-giver a few simple exercises, strengthen her, restore confidence and improve safety.
I live in Israel that has public health care – the default is option 1 which is neither cost nor medically-effective. Option 2 (a PT) is available but for some strange reason, GP in Israel prefer to use high-priced doctors rather than low-cost PTs.
Making the right choice (PT over MD) is a consumer choice that requires education or a medical choice that requires integrity. Either way – it’s Pay for Value.
Danny Lieberman
Tried to leave a Trackback, but for some reason it did not register —
CONVERGENCES – Recognizing One’s True Interest
http://convergencelaw.typepad.com/convergences/2009/07/recognizing-ones-true-interest.html
I really enjoy reading this blog. I have put together a website on health reform that touches on many of the issues on this site. I would love for any or all of you to visit and both enjoy its content and let me know what you think.
The ads for all visits go to charity to fight Ulcerative Colitis too!
http://www.satvathealthcare.com
Best,
Amir
Thanks in advance.
While the open letter was outstanding, there is a point I do not understand.
I am currently under Medicare parts A and B, plus I have additional insurance to cover costs not covered by Medicare. Does the new plan proposed require that a hospital accept the payments from Medicare without requiring any additional payments?
I understand that under Medicaid, making additional payments, either out-of-pocket, or from additional insurance is prohibited in most States.
Any clarification would be appreciated
Is it legal for me to have http://www.web-chamber.com – offshore companies explained here?, and bank accounts? How to start? Can I move my existing business offshore
Thanks
I caught only portions of Dr. Cortese’s aooearance with Charlie Rose. Can you provide me a transcript? In any event, can you email me the text(s) of your Policy Center views on national healthcare and insurance policy?
2 Trackbacks
[...] approach for health care – see the discussion on pay for value in health care in the open letter to congress Categories: Physical security Tags: business threat modeling, Pharmaceutical, Risk and strategy, [...]
Recognizing One’s True Interest…
Many posts on this blog (here; here; here) argue that “keeping costs down” is only one consumer interest, and not always a high-priority one, whether the topic is medical care, pharmaceutical research, intellectual property, or tech generally. The Ma…